Brind.

Partnership between Jazz Pharmaceuticals, AbCellera, and PharmaMar leverages an antibody discovery engine for a biopharmaceutical based in Ireland.

4 reports, 4 independent Updated Jun 17
Gone quiet Reached 4 outlets in its first 24 hours
Reports
4
Developments
2
Repetition
50%

New informationRepeats or wire copies

AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Well supportedReported by 4 independent outlets

Partnership between Jazz Pharmaceuticals, AbCellera, and PharmaMar leverages an antibody discovery engine for a biopharmaceutical based in Ireland.

Who's involved

What this event is mainly about
Jazz PharmaceuticalsAbCelleraIrelandPharmaMar

How it developed

Newest first. Tap a step to see who reported it.
  1. Announced collaboration with AbCellera to develop TCE multispecific antibodies.1 source
  2. Details of a Phase 3 trial for an Ireland-domiciled biopharmaceutical involving Jazz and AbCellera.1 source

Keep exploring

The entities involved

Coverage

Newest first; wire copies grouped